- Home
- API vs ABSI Comparison
API vs ABSI Comparison
Compare API & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- ABSI
- Stock Information
- Founded
- API 2013
- ABSI 2011
- Country
- API United States
- ABSI United States
- Employees
- API N/A
- ABSI N/A
- Industry
- API Computer Software: Prepackaged Software
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- API Technology
- ABSI Health Care
- Exchange
- API Nasdaq
- ABSI Nasdaq
- Market Cap
- API 343.2M
- ABSI 338.0M
- IPO Year
- API 2020
- ABSI 2021
- Fundamental
- Price
- API $3.45
- ABSI $2.39
- Analyst Decision
- API Strong Buy
- ABSI Strong Buy
- Analyst Count
- API 1
- ABSI 5
- Target Price
- API $6.00
- ABSI $7.98
- AVG Volume (30 Days)
- API 508.9K
- ABSI 4.4M
- Earning Date
- API 08-18-2025
- ABSI 08-12-2025
- Dividend Yield
- API N/A
- ABSI N/A
- EPS Growth
- API N/A
- ABSI N/A
- EPS
- API N/A
- ABSI N/A
- Revenue
- API $133,554,000.00
- ABSI $4,138,000.00
- Revenue This Year
- API $7.20
- ABSI $44.71
- Revenue Next Year
- API $11.26
- ABSI $374.26
- P/E Ratio
- API N/A
- ABSI N/A
- Revenue Growth
- API N/A
- ABSI 27.32
- 52 Week Low
- API $1.78
- ABSI $2.01
- 52 Week High
- API $6.99
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- API 40.21
- ABSI 33.33
- Support Level
- API $3.48
- ABSI $2.50
- Resistance Level
- API $3.67
- ABSI $2.73
- Average True Range (ATR)
- API 0.19
- ABSI 0.18
- MACD
- API -0.02
- ABSI -0.04
- Stochastic Oscillator
- API 10.17
- ABSI 1.94
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.